Page last updated: 2024-10-22

altretamine and Neoplasm Metastasis, Unknown Primary

altretamine has been researched along with Neoplasm Metastasis, Unknown Primary in 2 studies

Altretamine: A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BĂ©couarn, Y1
Brunet, R1
Barbé-Gaston, C1
Strnad, CM1
Grosh, WW1
Baxter, J1
Burnett, LS1
Jones, HW1
Greco, FA1
Hainsworth, JD1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Randomized Phase III Trial of Conventional Paclitaxel and Carboplatin Versus Dose Dense Weekly Paclitaxel and Carboplatin in Patients With Newly Diagnosed Stage II-IV Mullerian Carcinoma[NCT00226915]Phase 3637 participants (Actual)Interventional2003-04-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for altretamine and Neoplasm Metastasis, Unknown Primary

ArticleYear
Fluorouracil, doxorubicin, cisplatin and altretamine in the treatment of metastatic carcinoma of unknown primary.
    European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:5

    Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Fe

1989
Peritoneal carcinomatosis of unknown primary site in women. A distinctive subset of adenocarcinoma.
    Annals of internal medicine, 1989, Aug-01, Volume: 111, Issue:3

    Topics: Adenocarcinoma; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Mod

1989